Open study of clarithromycin for the treatment of infections caused by nontuberculous mycobacteria (NTM)
Phase of Trial: Phase IV
Latest Information Update: 25 May 2017
At a glance
- Drugs Clarithromycin (Primary)
- Indications Mycobacterial infections; Mycobacterium avium complex infections
- Focus Therapeutic Use
- 18 May 2017 Status changed from active, no longer recruiting to completed.
- 29 Feb 2008 New trial record.